Pengfei Zhou

机构：First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Wuhan YZY Biopharma (China), First Affiliated Hospital of Henan University, First Affiliated Hospital of Zhengzhou University, Chinese People's Liberation Army, Jinhua Central Hospital · ORCID：0000-0003-2181-3804

发表论文 87 篇 · 总被引 2254 次 · h-index 26

代表论文

• Anti-TGF-β/PD-L1 bispecific antibody synergizes with radiotherapy to enhance antitumor immunity and mitigate radiation-induced pulmonary fibrosis (2025 · Journal of Hematology & Oncology · 被引 35)
• Triple targeting of STING, TGF-β, and PD-L1 boosts CXCL16–CXCR6 signaling for potent antitumor response (2026 · Nature Communications · 被引 13)
• Targeting pyroptosis reverses KIAA1199-mediated immunotherapy resistance in colorectal cancer (2025 · Journal for ImmunoTherapy of Cancer · 被引 10)
• AI-Assisted Analysis for Breast Cancer Imaging and Diagnostics (2025 · International Journal on Robotics Automation and Sciences · 被引 3)
• Development and clinical trial of M701, an Anti-EpCAM × Anti-CD3 bispecific antibody: a targeted intraperitoneal therapy for malignant ascites stemming from advanced solid tumors (2025 · Experimental Hematology and Oncology · 被引 2)
• HLA-B27 modulates the composition of the gut microbiota and drives a proinflammatory intestinal microecology (2025 · Human Immunology · 被引 1)